Robert C. Goeltz II insider trades

Open-market stock purchases and sales by Robert C. Goeltz II, Chief Financial Officer at Arcus Biosciences, Inc, from SEC Form 4 filings since Jan 21, 2016.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +43%.

Recent trades

DateStockTradeValue
May 11, 2026RCUS Arcus Biosciences, IncSold$199K
Jan 23, 2026RCUS Arcus Biosciences, IncBought (not open market)—
Jan 23, 2026RCUS Arcus Biosciences, IncBought (not open market)—
Dec 31, 2025RCUS Arcus Biosciences, IncSold$153K
Dec 17, 2025RCUS Arcus Biosciences, IncSold$132K
Dec 16, 2025RCUS Arcus Biosciences, IncSold$147K
Nov 26, 2025RCUS Arcus Biosciences, IncSold$125K
Oct 28, 2025RCUS Arcus Biosciences, IncSold$100K

Companies traded

  • RCUS Arcus Biosciences, Inc: 1 buy, 17 sales, last May 11, 2026
  • UBX Unity Biotechnology, Inc: other filings, last Jun 22, 2020
  • CTMX CytomX Therapeutics, Inc: 2 sales, last May 12, 2017

Get free alerts when Robert C. Goeltz II files a new trade →